Drug Trial Radar · NCT05503797
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
254
Planned (sponsor's estimate)
Start
Feb 21, 2023
Primary completion
Dec 31, 2027
Study completion Dec 28, 2028
Sponsor
- Lead sponsor
- Fore BiotherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 8 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors, including rare BRAF V600E-mutated solid tumors, including anaplastic thyroid, ovarian, cholangiocarcinoma or other rare cancers.
Conditions
- Cancer Harboring BRAF Alterations
- HGG
- LGG
- Solid Tumors
Interventions
PlixorafenibDrug
Oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR) (Subprotocols A, B and C)Time frame: Up to approximately 4 years
- Pharmacokinetics (Subprotocol D)Time frame: Up to approximately 4 years
Locations
70 sites in 12 countries. Site status is shown where the registry gives one.
Precision NextGen Oncology & Research Center
Beverly Hills, California · Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California · Recruiting
University of California Los Angeles Rheumatology
Westwood, Los Angeles, California · Recruiting
Norwalk Hospital
Norwalk, Connecticut · Recruiting
University of Miami Hospital and Clinics
Miami, Florida · Recruiting
The John Hopkins Hospital
Baltimore, Maryland · Recruiting
Maryland Oncology Hematology- Columbia
Rockville, Maryland · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Not yet recruiting
St. Luke's Hospital
Duluth, Minnesota · Recruiting
Mosaic Life Care at Saint Joseph - Medical Center
Saint Joseph, Missouri · Recruiting
Nebraska Cancer Specialists - Midwest Cancer Center - Legacy
Omaha, Nebraska · Recruiting
Overlook Medical Center
Summit, New Jersey · Recruiting
Columbia University Irving Medical Center
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Atrium Health Wake Forest Baptist - Comprehensive Cancer Center
Winston-Salem, North Carolina · Recruiting
Nationwide Children's Hospital
Colombus, Ohio · Recruiting
The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute
Columbus, Ohio · Recruiting
Taylor Cancer Research Center
Maumee, Ohio · Recruiting
Toledo Clinic Cancer Center
Toledo, Ohio · Completed
Thomas Jefferson University
Philadelphia, Pennsylvania · Recruiting
Lifespan Cancer Institute - Rhode Island Hospital
Providence, Rhode Island · Recruiting
SCRI - TriStar Medical Group Children's Specialists
Nashville, Tennessee · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Baylor Scott & White Research Institute
Dallas, Texas · Recruiting
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Baylor Scott & White Medical Center
Temple, Texas · Recruiting
University of Washington School of Medicine
Seattle, Washington · Recruiting
West Virginia University Health Sciences Campus
Morgantown, West Virginia · Recruiting
Newcastle Private Hospital
New Lambton Heights, New South Wales, Australia · Recruiting
Orange Health Service
Orange, New South Wales, Australia · Recruiting
Sydney Children's Hospital Network - Randwick
Randwick, New South Wales, Australia · Recruiting
Flinders Medical Centre
Bedford Park, South Australia, Australia · Recruiting
The Alfred
Melbourne, Victoria, Australia · Recruiting
Sunny brook Health Sciences Centre- Bayview Campus
Toronto, Ontario, Canada · Recruiting
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada · Recruiting
Institut Universitaire du Cancer de Toulouse Oncopole
Toulouse, France · Recruiting
Institut Bergonie
Bordeaux, Aquitaine, France · Recruiting
Hôpital Nord de Marseille
Marseille, Bouches-du-Rhône, France · Recruiting
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.